Diligence memo · auto-generated · as of July 2, 2026
Aledade, Inc.
Aledade, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Aledade, Inc. operates in Healthtech, based in BETHESDA. Aledade is a national leader empowering primary care organizations with actionable insights to improve patient health and support business sustainability.
Sub-sector tags: climate/cleantech, healthtech.
Capital & rounds (filed)filed
Aledade, Inc. has raised $663M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $260M on 2023-06-07.
Most recent recorded round closed around 2023-06-07.
Valuation (modeled)modeled
Provath models Aledade, Inc. at approximately $3.5B (range $1.4B–$5.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.86× the median modeled value of Series D+ Healthtech companies in 2022–2024 (17 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 3.1 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 2.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 100% of Healthtech peers (2138 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Monogram Health Holdings, Inc., Lyra Health, Inc., Clarify Health Solutions, Inc., Insightec Ltd, Nalu Medical, Inc..
Peoplefiled
20 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.